Skip to content

Hepatitis C still increasing in German gay men with HIV, reinfection common

New tool developed to predict success of hepatitis C therapy in HIV/HCV-co-infected patients

High hepatitis C mortality and low clearance rates in HIV/HCV-co-infected patients in France

Accelerated hepatitis B vaccine schedule boosts completion rates in IDUs

HIV/HCV co-infected women more likely to stop HCV therapy

Nevirapine toxicity in women predicted by liver function, not CD4 count, developing country study reports

HCV protease inhibitors likely to work for co-infected patients previously treated for HCV

Thai activists call for treatment for hepatitis C for people with HIV

Chronic hepatitis C infection blunts CD4 gains after start of HIV treatment